Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma Study
Dec 05, 2016 12:30 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Dec. 05, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated a study of its NY‑ESO SPEAR™...
Centennial Resource Development Announces Commitments for $910 Million Private Placement of Equity
Dec 05, 2016 12:05 pm UTC| Business
DENVER, Dec. 05, 2016 -- Centennial Resource Development, Inc. together with its affiliates (“CDEV”, “Centennial” or the “Company”) (NASDAQ:CDEV) (NASDAQ:CDEVW), today announced that it has entered into agreements to...
Dec 05, 2016 12:05 pm UTC| Business
– MAT2501 previously received Orphan Drug and Qualified Infectious Disease Product designations for treatment of nontuberculous mycobacterium infections by U.S. FDA – – Phase 1 data expected in the first half of 2017 –...
Dec 05, 2016 12:04 pm UTC| Business
WATERTOWN, Mass., Dec. 05, 2016 -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company developing a novel class of targeted antigen-specific immune therapies, announced today that it will...
GasLog Ltd. Announces Order of FSRU Long Lead Items for LNG Carrier Conversion
Dec 05, 2016 12:04 pm UTC| Business
MONACO, Dec. 05, 2016 -- GasLog Ltd. ("GasLog", NYSE: GLOG), aninternational owner, operator and manager of liquefied natural gas ("LNG") carriers, today announces that Keppel Shipyard Limited ("Keppel") has begun...
Spark Therapeutics Adds Chief Operating Officer to Management Team
Dec 05, 2016 12:01 pm UTC| Business
PHILADELPHIA, Dec. 05, 2016 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the appointment of John Furey to...
Dec 05, 2016 12:01 pm UTC| Business
--35% Complete Remission (CR) Rate for Combination in 1st-line Higher-risk MDS Patients-- --Updated Median Duration of Complete Response of 8 Months in All Responding Patients-- NEWTOWN, Pa., Dec. 05, 2016 --...